MENHIBRIX - Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine
Navigation:
NDC >
Supplier starting with: G > GLAXOSMITHKLINE BIOLOGICALS SA
Field |
Value |
NDC Code: |
58160-809 |
Proprietary Name: |
MENHIBRIX |
Suffix: |
|
Non-Proprietary Name: |
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
Dosage Form: |
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Method: |
INTRAMUSCULAR |
Original Marketing Date: |
03-09-2013 |
Category Name: |
BLA |
Application Number: |
BLA125363 |
Labeler: |
GLAXOSMITHKLINE BIOLOGICALS SA |
Substance Name: |
HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN; NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE ANTIGEN; NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE ANTIGEN |
Active Numerator Strength: |
2.5; 5; 5 |
Active Ingredient Unit: |
ug/.5mL; ug/.5mL; ug/.5mL |
Pharm Classes: |
Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Meningococcal Vaccine [EPC],Actively Acquired Immunity [PE],Meningococcal Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient],Inactivated Haemophilus Influenzae B Vaccine [EPC],Actively Acquired Immunity [PE],Haemophilus Vaccines [Chemical/Ingredient],Vaccines, Inactivated [Chemical/Ingredient] |
DEA Schedule: |
|